Lumina Pharmaceuticals Inc.
BOSTON, MA · Founded 2025 · CIK 0002069952 · Software
Decision software with influence diagrams and Monte Carlo simulation capabilities for analytics
analytica.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 0
- Raised
- $2.0M
- 1 Form D · Jun 2025
- 16 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 0
Capital Timeline
Federal ↑Equity ↓20242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2797 | BackOps-ai Inc. | — | $35M |
| 2798 | eBrevia, Inc. | — | $2.8M |
| 2799 | AR2 Project, LLC | — | $1 |
| 2800 | Lumina Pharmaceuticals Inc. | — | $2.0M |
| 2801 | Lagena Inc. | — | $80K |
| 2802 | Voice Eval Systems, Inc. | — | $505K |
| 2803 | Anodet Inc. | — | $3.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Peter CaravanDirector
- Cara FerreiraDirector · Executive Officer
- Alma SorensenDirector · Executive Officer
Patents
- Fibrin-binding Compounds For Imaging And Treatmentapplication
- Contrast Agents For Collagen And Fibrin Imagingapplication
- Contrast Agents For Collagen And Fibrin Imagingapplication